94 related articles for article (PubMed ID: 1837442)
1. The antitumor effect of a novel nitrosourea, tauromustine, at intravenous administration in rat. Cure of hepatomas.
Roos G; el Hag IA; Christensson PI; Stenram U
Anticancer Res; 1991; 11(5):1763-6. PubMed ID: 1837442
[TBL] [Abstract][Full Text] [Related]
2. Improved antitumor effect of the nitrosourea drugs tauromustine (TCNU) and carmustine (BCNU) on a rat liver adenocarcinoma after hepatic arterial administration with degradable starch microspheres.
Roos G; el Hag IA; Teder H; Stenram U
Anticancer Res; 1991; 11(1):13-6. PubMed ID: 2018346
[TBL] [Abstract][Full Text] [Related]
3. Sequence-dependent activity of 5-fluorouracil plus tauromustine in a transplantable well-differentiated murine colon adenocarcinoma.
Hill SR; Pollard LA; Bibby MC
Anticancer Res; 1992; 12(6B):2169-75. PubMed ID: 1295464
[TBL] [Abstract][Full Text] [Related]
4. Degradable starch microspheres in cytostatic treatment of a liver carcinoma; experimental studies in rats with 5-fluorouracil, tauromustine, carmustine, doxorubicin and RSU-1069.
Roos G; Christensson PI; el Hag IA; Jakobsson B; Teder H; Stenram U
Anticancer Res; 1993; 13(3):635-41. PubMed ID: 8317891
[TBL] [Abstract][Full Text] [Related]
5. Effect of sodium benzylideneascorbate on chemically-induced tumors in rats.
Sakagami H; Takeda M; Utsumi A; Fujinaga S; Tsunoda A; Yasuda N; Shibusawa M; Koike T; Ota H; Kazama K
Anticancer Res; 1993; 13(1):65-71. PubMed ID: 8386496
[TBL] [Abstract][Full Text] [Related]
6. Tauromustine is more effective than conventional chemotherapy in the treatment of colonic tumors.
Singh G; Graffner HO; Milsom JW; Chaudry IH
Dis Colon Rectum; 1993 Apr; 36(4):394-9. PubMed ID: 8458268
[TBL] [Abstract][Full Text] [Related]
7. The effect of different dose levels of degradable starch microspheres (Spherex) on the distribution of a cytotoxic drug after regional administration to tumour-bearing rats.
Teder H; Johansson CJ; d'Argy R; Lundin N; Gunnarsson PO
Eur J Cancer; 1995 Sep; 31A(10):1701-5. PubMed ID: 7488428
[TBL] [Abstract][Full Text] [Related]
8. Response to chemotherapy of non-small cell bronchial rat tumours growing subcutaneously or in the lung.
Kal HB; Meijnders PJ; Van Berkel AH; Van Bekkum DW
In Vivo; 1991; 5(4):301-6. PubMed ID: 1810413
[TBL] [Abstract][Full Text] [Related]
9. Tauromustine (TCNU) combined with 5-fluorouracil and leucovorin in the treatment of advanced colon cancer.
Taal BG; Ten Bokkel Huinink WW; Rodenhuis S
Eur J Cancer; 1993; 29A(13):1916-7. PubMed ID: 8260256
[No Abstract] [Full Text] [Related]
10. Effects of routes of administration of TCNU on its plasma, tissue and tumour concentrations.
Double JA; Bibby MC; Loadman PM; Bloomer JC
Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1355-60. PubMed ID: 3181256
[TBL] [Abstract][Full Text] [Related]
11. Leukopoiesis is not affected after intravenous treatment with the novel antineoplastic agent taurolidine. Results of an experimental study in rats.
Braumann C; Menenakos C; Atanassov V; Pfirrmann RW; Guenther N; Jacobi CA
Eur Surg Res; 2008; 40(4):341-6. PubMed ID: 18303270
[TBL] [Abstract][Full Text] [Related]
12. Chromosome aberrations and pharmacokinetics in patients receiving tauromustine as either a single or a repeated dose.
Hartley-Asp B; Hansson K; Vibe-Petersen J; Hansen HH; Polacek J; Ellman M; Gunnarsson PO
Cancer Chemother Pharmacol; 1996; 38(4):309-16. PubMed ID: 8674152
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats.
Shirasaka T; Nakano K; Takechi T; Satake H; Uchida J; Fujioka A; Saito H; Okabe H; Oyama K; Takeda S; Unemi N; Fukushima M
Cancer Res; 1996 Jun; 56(11):2602-6. PubMed ID: 8653704
[TBL] [Abstract][Full Text] [Related]
14. [Antitumor spectrum of TUT-7 on rat ascitic hepatoma].
Satoh H; Taguchi H; Yahagi S
Gan To Kagaku Ryoho; 1990 Feb; 17(2):287-91. PubMed ID: 2137321
[TBL] [Abstract][Full Text] [Related]
15. [Intrathecal ACNU for the treatment of a meningeal gliomatosis model].
Yoshida T; Shimizu K; Mogami H; Egawa T; Sakamoto Y
Gan To Kagaku Ryoho; 1987 Jan; 14(1):84-90. PubMed ID: 3467657
[TBL] [Abstract][Full Text] [Related]
16. 4-aminoazobenzene and N,N-dimethyl-4-aminoazobenzene as equipotent hepatic carcinogens in male C57BL/6 X C3H/He F1 mice and characterization of N-(Deoxyguanosin-8-yl)-4-aminoazobenzene as the major persistent hepatic DNA-bound dye in these mice.
Delclos KB; Tarpley WG; Miller EC; Miller JA
Cancer Res; 1984 Jun; 44(6):2540-50. PubMed ID: 6426782
[TBL] [Abstract][Full Text] [Related]
17. Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer.
Smyth JF; Hardcastle JD; Denton G; Alderson D; Grace RH; Mansi JL; Yosef HM; Nordle O; Lauri H; Wählby S
Ann Oncol; 1995 Nov; 6(9):948-9. PubMed ID: 8624301
[No Abstract] [Full Text] [Related]
18. [Experimental studies on oral administration of nitrosourea anti-tumor agent, MCNU].
Sekido S; Ninomiya K; Araki T; Ueno M; Kinbara M
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1492-500. PubMed ID: 6234861
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of a novel nitrosourea, tauromustine, in the rat.
Seidegård J; Grönquist L; Gunnarsson PO
Biochem Pharmacol; 1990 May; 39(9):1431-6. PubMed ID: 2334443
[TBL] [Abstract][Full Text] [Related]
20. Influence of hydralazine on the pharmacokinetics of tauromustine (TCNU) in mice.
Bibby MC; Loadman PM; al-Ghabban AF; Double JA
Br J Cancer; 1992 Mar; 65(3):347-50. PubMed ID: 1558786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
